United States · FDA National Drug Code directory

ELIQUIS

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71610-662_2ceefa5f-84de-f3d9-e063-6394a90a6dc5
Product NDC
71610-662
Form
TABLET, FILM COATED
Composition / generic term
apixaban
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Marketing category
NDA
Marketing start / end (source format)
20121228
Source listing expiry
20261231

Source-listed ingredients

  • APIXABAN — 5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 9000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-09) · 71610-662-09
  • 3000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-18) · 71610-662-18
  • 1800 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-42) · 71610-662-42
  • 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-662-80) · 71610-662-80

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →